A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/phase-3-rapid-relief-thyroid-eye-disease-veligrotug-2026a1000ifw?src=rss
Author :
Publish date : 2026-06-03 06:54:00
Copyright for syndicated content belongs to the linked Source.
